Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FAST Lidocaine for Topical Anesthesia
NCT01145326Phase 3Withdrawn
- Sponsor
- University of Oklahoma
- Start
- Jan 2015
- Primary completion
- Dec 2017
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of lidocaine 10% oropharyngeal spray in pain, sponsored by University of Oklahoma. Primary endpoint: Venipuncture pain levels at 1 hour. Planned start Jan 2015; status: withdrawn.
02
Drugs
lidocaine 10% oropharyngeal spray
03
Conditions
pain
Beyond the preview
Go deeper on NCT01145326.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01145326.